Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.99 USD | -2.61% | +5.06% | +58.89% |
Jun. 11 | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
May. 29 | Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.89% | 1.03B | |
+18.34% | 124B | |
+15.06% | 109B | |
-6.39% | 23.84B | |
+0.67% | 22.42B | |
-15.27% | 17.5B | |
-41.64% | 16.43B | |
-12.07% | 16.61B | |
+1.05% | 13.4B | |
+25.87% | 11.47B |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.
- Enliven Therapeutics Q3 Loss Narrows